Victory Capital Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-5,732
| Closed | -$754K | – | 2802 |
|
|
2020
Q4 | $754K | Sell |
5,732
-47,377
| -89% | -$6.23M | ﹤0.01% | 1895 |
|
|
2020
Q3 | $2.68M | Sell |
53,109
-6,405
| -11% | -$324K | ﹤0.01% | 1362 |
|
|
2020
Q2 | $2.84M | Sell |
59,514
-279,940
| -82% | -$13.3M | ﹤0.01% | 1324 |
|
|
2020
Q1 | $16.6M | Buy |
339,454
+164,652
| +94% | +$8.07M | 0.01% | 942 |
|
|
2019
Q4 | $10M | Sell |
174,802
-94,101
| -35% | -$5.4M | 0.01% | 1012 |
|
|
2019
Q3 | $9.67M | Buy |
268,903
+158,173
| +143% | +$5.69M | 0.01% | 994 |
|
|
2019
Q2 | $3.44M | Sell |
110,730
-72,440
| -40% | -$2.25M | 0.01% | 1001 |
|
|
2019
Q1 | $4.3M | Sell |
183,170
-22,850
| -11% | -$536K | 0.01% | 881 |
|
|
2018
Q4 | $2.84M | Buy |
+206,020
| New | +$2.84M | 0.01% | 950 |
|